Cynata Receives Ethics Approval to Commence Clinical Trial in COVID-19 and Clinical Development Update

Ads

You May Also Like

Sun BioPharma, Inc. Provides a Business Update and Files Report for Q2 2018

First Patients Enrolled in Front-Line Combination Study of SBP-101 with Gemcitabine and nab-Paclitaxel for ...

Athenex Announces Recent Product Launches in 503B and Specialty Injectables Business Units

BUFFALO, N.Y., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical ...

Prima Secures Japanese Patent Grant for Lead Product IMP321 in Infectious Disease

SYDNEY, Australia, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”, ...